Precision Biosciences Inc

Precision BioSciences Reports Third Quarter 2026 Financial Results and Provides Business Update

- PBGENE-HBV late-breaking oral presentation for ELIMINATE-B trial at AASLD's The Liver Meeting® 2026 on November 8; data abstract scheduled for…